Paper10694562
Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis.
Poon RT and 5 others. J Clin Oncol, 2000. Cited by 164 papers, by iCite.
Cite this record
ConductScience Library. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. Papers, record 10694562. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10694562
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Hepatitis B | Major topic |
| Liver Cirrhosis | Major topic |
| Liver Neoplasms | Major topic |
| Disease-Free Survival | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Prognosis | |
| Prospective Studies | |
| Survival Analysis |
Source PubMed
Cited by58
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 164 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42568414 | Liver resection is associated with better survival than TACE for hepatocellular carcinoma modestly beyond Milan criteria: a multicenter propensity-matched analysis. | Front Oncol | 2026 | https://conductscience.org/library/papers/42568414 | PubMed |
| 41484570 | Adjuvant anlotinib plus TACE in hepatocellular carcinoma with postoperative high-risk recurrence: a single-arm, multi-center, phase II study. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/41484570 | PubMed |
| 40796708 | Laparoscopic versus open repeat liver resection for recurrent liver cancer: an updated systematic review and meta-analysis. | Updates Surg | 2025 | https://conductscience.org/library/papers/40796708 | PubMed |
| 36050540 | Vessels that encapsulate tumor clusters (VETC) pattern predicts the efficacy of adjuvant TACE in hepatocellular carcinoma. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/36050540 | PubMed |
| 35734623 | Laparoscopic vs open liver re-resection for cirrhotic patients with post-hepatectomy hepatocellular carcinoma recurrence: A comparative study. | World J Gastrointest Surg | 2022 | https://conductscience.org/library/papers/35734623 | PubMed |
| 35723760 | The efficacy of transarterial chemoembolization in downstaging unresectable hepatocellular carcinoma to curative therapy: a predicted regression model. | Invest New Drugs | 2022 | https://conductscience.org/library/papers/35723760 | PubMed |
| 35211422 | The AST/ALT Ratio (De Ritis Ratio) Represents an Unfavorable Prognosis in Patients in Early-Stage SFTS: An Observational Cohort Study. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/35211422 | PubMed |
| 34539896 | Preoperative Versus Postoperative Transarterial Chemoembolization on Prognosis of Large Hepatocellular Carcinoma. | J Cancer | 2021 | https://conductscience.org/library/papers/34539896 | PubMed |
| 34430571 | Nomogram for predicting pathologic complete response after transarterial chemoembolization in patients with hepatocellular carcinoma. | Ann Transl Med | 2021 | https://conductscience.org/library/papers/34430571 | PubMed |
| 33996606 | Efficacy of Liver Resection for Single Large Hepatocellular Carcinoma in Child-Pugh A Cirrhosis: Analysis of a Nationwide Cancer Registry Database. | Front Oncol | 2021 | https://conductscience.org/library/papers/33996606 | PubMed |
| 33725402 | A Transcriptomic Signature for Risk-Stratification and Recurrence Prediction in Intrahepatic Cholangiocarcinoma. | Hepatology | 2021 | https://conductscience.org/library/papers/33725402 | PubMed |
| 33442451 | Comparison between hepatocellular carcinoma prognostic scores: A 10-year single-center experience and brief review of the current literature. | World J Hepatol | 2020 | https://conductscience.org/library/papers/33442451 | PubMed |
| 33394207 | Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare. | Cancer Causes Control | 2021 | https://conductscience.org/library/papers/33394207 | PubMed |
| 33234055 | The Prognostic Value of Circulating VEGF-A Level in Patients With Hepatocellular Cancer. | Technol Cancer Res Treat | 2020 | https://conductscience.org/library/papers/33234055 | PubMed |
| 33003646 | Circulatory miRNA as a Biomarker for Therapy Response and Disease-Free Survival in Hepatocellular Carcinoma. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33003646 | PubMed |
| 32368139 | Long-Term Survival in Patients Receiving Combination Therapy with Resection and Radiofrequency Ablation for Multi-Focal Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage B: A Retrospective Controlled Study. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/32368139 | PubMed |
| 31674731 | Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma. | Cancer Med | 2019 | https://conductscience.org/library/papers/31674731 | PubMed |
| 31342257 | Comparison of clinical outcomes of laparoscopic versus open surgery for recurrent hepatocellular carcinoma: a meta-analysis. | Surg Endosc | 2019 | https://conductscience.org/library/papers/31342257 | PubMed |
| 31136302 | Beneficial effects of Cripto-1 for transarterial chemoembolization in hepatocellular carcinoma. | Aging (Albany NY) | 2019 | https://conductscience.org/library/papers/31136302 | PubMed |
| 31020447 | Inflammation-nutrition score predicts prognosis of patients with resectable hepatocellular carcinoma. | Int J Clin Oncol | 2019 | https://conductscience.org/library/papers/31020447 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10694562
GET https://conductscience.org/api/papers/v1/10694562/cited_by?page=2